New hope for Tough-to-Treat colon cancer?
Disease control
Terminated
This study tested a new drug combination (NUFIRI-bev) against the standard treatment (FOLFIRI-bev) for people with advanced colorectal cancer that had spread and could not be removed by surgery. The goal was to see if the new combination was more effective and safer for patients …
Phase: PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC